Get started

Buy-signal

BBIG Vinco Ventures the next TikTok???BBIG announced the closing of the Lomotif Private Limited acquisition. Lomotif, TikTok`s rival, is one of the top short form video platforms in the world with hundreds of millions of installs around the world and tens of millions of monthly users and over 31 million on-platform monthly active users. Buying this stock could be like getting into TikTok early. Third-party independent valuation shows the combined companies have a valuation over $5 billion as of June 30 according to recent private financing comparable valuation by Gemini Valuation Services. Now the MARKET CAP is only 813Mil. Based on the Fibonacci extension tool, i see a 11.17usd price target short term and 500% upside one year term.
BLong
by TopgOptions
2
EGLD/USDT has reached the support point and I think it is readEGLD/USDT has reached the support point and I think it is ready to move up. The EGLD/USDT has hit relatively strong support at $ 246 and I expect it to move up. RSI and MACD chart show a exaggerated divergence. (+ED) Of course, we have to wait for a positive move to happen on the chart and we will not buy now. In the MACD chart, you have to wait for the SIGNAL line to move up (the same blue line in the MACD) Target : 256 / 264 / 270 / 276 / 283 Stop lost : 240 Note that all analysis is done according to the current market conditions and if something special happens to Bitcoin, it can affect all Altcoins and lead to a fundamental market instead of a technical one. This is just a suggestion based on my own analysis. You are responsible for your own sales. I apologize if I explained somewhere wrong and thank you very much for reading my article.
Long
by Aminzahedi1385
1
ACXP cheaper than the public offeringAcurx filed a provisional patent application with the U.S. Patent and Trademark Office for use of ibezapolstat to treat C. difficile Infection (CDI) while reducing recurrence of infection and improving the health of the gut microbiome. In January 2019, FDA granted "Fast Track" designation to ibezapolstat for the treatment of patients with CDI. The Company successfully completed Phase 1 and Phase 2a clinical trials of ibezapolstat and in the second half of 2021. (prnewswire.com)
NASDAQ:ACXPLong
by TopgOptions
$GLBS FALLING WEDGE BULLISH REVERSALGlobus Maritime (UPDATE) Currently $3.07 & Targets $35 - $100 Technical Analysis: Bullish Chart Pattern: Falling Wedge Bullish Reversal RSI: Slowly Going Up & Signal For Trend Reversal Volume: Low & Calm Before Storm Fundamental Analysis: Bullish EPS: Expected Late Sept & Extremely Bullish There is huge upside considering $BDI is at a 11 Year High! Also Globus Maritime Stock is near alltime lows of $2.55 & there’s an incredible opportunity for growth. The dry bulk industry can expect major recovery and profits. Retail Investors Are Expected To Be Massively Rewarded!
NASDAQ:GLBSLong
by UnknownUnicorn2208604
3
OEG Orbital Energy increased Institutional Ownership On 7/26/2021 Alliance Global Partners brokerage Lowered the Price Target for OEG from $15.00 to $12.00 It`s interesting to see how this month only the institutions increased their ownership in the company with 22mil. Some of the Companies that reported increased ownership in Orbital Energy this months are: Increased ownership in Millennium Management LLC by +326.9% Morgan Stanley by +134.2% Vanguard Group Inc. by +17.7% Morgan Stanley by +84.4% My first target is the 4.5 resistance from which can skyrocket
OLong
by TopgOptions
1
PIRS Pieris Pharmaceuticals Huge Upside Potential Big pharma working with Pieris Pharmaceuticals, Inc. (PIRS): AZN AstraZeneca 70Mil upfront payment and 5.4Bil potential milestone payments Boston Pharmaceuticals 10Mil upfront payment and 353Mil potential milestone payments Genentech member of RHHBY Roche Group 20Mil upfront payment and 1.4Bil potential milestone payments SGEN Seagen 35Mil upfront payment and 1.2Bil potential milestone payments Servier 40Mil upfront payment and 447Mil potential milestone payments inhaled program PRS-220 for the treatment of IPF. selected to receive a Bavarian government grant of approximately $17 million to evaluate the program for post-COVID pulmonary fibrosis On 8/16/2021 Morgan Stanley reported 1,675,969 shares of PIRS for $6.42Mil, an increase of +104.6% for an ownership of 2.512% in the company On 4/26/2021 HC Wainwright brokerage Reiterated Rating to Buy and a price target of $9.00 On 6/30/2021 Jefferies Financial Group brokerage Boosted Price Target to Buy from $6.00 to $8.00 Usually i have price targets lower than most analysts, but on PIRS, my price target is 10usd. I`m looking forward to read your opinion about it.
PLong
by TopgOptions
4